期刊文献+

Leukotactin-1与动脉粥样硬化 被引量:2

暂未订购
导出
摘要 Leukotactin-1(Lkn-1)具有六个保守半胱氨酸,是CC亚群趋化因子新成员之一。具有生物学功能的Lkn-1肽链由92个氨基酸组成,分子量约10.162KD,基因定位于染色体17q12。CCR1和CCR3是Lkn-1的受体。经过Gi/Go蛋白,PLC,PKCδ,NF-κB和其他一些新合成的胞内蛋白传递趋化信号。Lkn-1对人外周血中性白细胞、单核细胞和淋巴细胞具有强大的化学趋化作用,与MCP-1和IL-8在动脉粥样硬化演变过程中可能具有协同作用。
作者 徐丽 凌文华
出处 《岭南急诊医学杂志》 2006年第2期160-160,F0003,共2页 Lingnan Journal of Emergency Medicine
  • 相关文献

同被引文献11

  • 1王娟,赵龙吟,司书毅.动脉粥样硬化过程中的炎症反应[J].中国分子心脏病学杂志,2004,4(4):238-242. 被引量:3
  • 2乔丽,张耀全,程悦,袁发焕.激素抵抗肾病综合征患者血清IL-1β和TNF-α的变化及意义[J].重庆医学,2006,35(23):2153-2154. 被引量:8
  • 3Rina Y, Chu-sook K, Teruo K, et al. Involvement of leukotaetin-1,a novel CC chamokine,in human atherosclerosis [J]. Atherosclerosis, 2004,174 (1) : 35.
  • 4Kim IS, Ryang YS,Kim YS, et al. Leukotactin-l-induced ERK activation is mediated via Gi/Go protein/PLC/PK- Cy/Ras cascades in HOS cells [J]. Life Sciences,2003,73(4):447.
  • 5Penn MS,Topoi EJ. Tissue factor,the emerging link between in flamma- tion, thrombosis, and vascular. Cia Res,2001,89 : 1-2.
  • 6Yu R,Kim CS,Kawada T,et al. Involvement of leukotactin-1 ,a novel CC chemokine ,in human atherosclerosis. Atherosclerosis,2004,174:35 42.
  • 7Davignon J. Beneficial cardiovascular pleiotmpic effects of statins. Circu- lation ,2004,109:3943.
  • 8Hoffmann R, Haager P, Suliman H, et al. Effect of statins therapy beibre Q-wave myocardial infarction on myocardial perfusion. Am J Cardiol, 2008,10l : 139-143.
  • 9Zhang YC,Wei JJ,Wang F,et al. Elevated levels of oxidized low-density lipoprptein correlate positively with C-reactive protein in patients with a- cute coronary syndrome. Cell Biochem Biophys,2012,62:365-372.
  • 10Lee WH, Kim SH ,Jeong EM, et al. A novel chemokine, Leukotactin-1, in- duces chemotaxis,pro-atherogenic cytokines, and tissue factor expression in atherosclerosis. Atherosclerosis ,2002,161:255-260.

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部